Silvercrest Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-118,265	Closed	-$9.88M	–	885
2024 Q4	$9.88M	Sell	118,265 -583	-0.5%	-$47.9K	0.07%	302
2024 Q3	$8.7M	Sell	118,848 -722	-0.6%	-$54.3K	0.06%	284
2024 Q2	$8.19M	Buy	119,570 +77,294	+183%	+$5.36M	0.06%	300
2024 Q1	$2.93M	Sell	42,276 -13,507	-24%	-$928K	0.02%	460
2023 Q4	$4M	Sell	55,783 -22,591	-29%	-$1.3M	0.03%	412
2023 Q3	$4.08M	Sell	78,374 -70	-0.1%	-$4.08K	0.03%	394
2023 Q2	$4.97M	Buy	78,444 +11,726	+18%	+$731K	0.04%	369
2023 Q1	$3.61M	Sell	66,718 -31,756	-32%	-$1.54M	0.03%	403
2022 Q4	$5.21M	Sell	98,474 -1,456	-1%	-$73K	0.04%	339
2022 Q3	$4.65M	Sell	99,930 -2,484	-2%	-$130K	0.04%	341
2022 Q2	$5.85M	Sell	102,414 -5,424	-5%	-$308K	0.04%	302
2022 Q1	$6.6M	Buy	107,838 +1,279	+1%	+$66.4K	0.04%	327
2021 Q4	$5.58M	Sell	106,559 -60,752	-36%	-$2.55M	0.04%	356
2021 Q3	$6.24M	Sell	167,311 -2,683	-2%	-$93.3K	0.04%	352
2021 Q2	$6.94M	Sell	169,994 -339	-0.2%	-$12.5K	0.05%	335
2021 Q1	$5.78M	Sell	170,333 -21,517	-11%	-$746K	0.04%	356
2020 Q4	$6.1M	Buy	+191,850	New	+$5.04M	0.04%	337